. 2023 Jul 28;4(7):e232247. doi: 10.1001/jamahealthforum.2023.2247

Table 2. Urine Drug Screen Completion Among Patients Receiving Telehealth-Based Treatment for Opioid Use Disorder With Buprenorphine.

Measure	Patients, No. (%)
Completed urine drug screen within 30 d^a	2782 (81.9)
Completed urine drug screen within 30 d, protocol-adherent patients^b	1988 (90.0)
Completed urine drug screen within 30 d, protocol-nonadherent patients^c	794 (67.0)
Completed urine drug screen within 90 d^d	2750 (97.6)
Completed urine drug screen within 180 d^e	2307 (99.7)
No. of urine drug screens in first 180 d, median (IQR)^e	3.0 (3.0-4.0)

^{^a}

Percentage calculated among all 3395 patients.

^{^b}

Percentage calculated among 2210 protocol-adherent patients.

^{^c}

Percentage calculated among 1185 protocol-nonadherent patients.

^{^d}

Percentage calculated among 2817 patients retained for at least 90 days.

^{^e}

Percentage and median calculated among 2314 patients retained for at least 180 days.